I. Stasi

Ospedale di Livorno — Italy

Medicine · Health Sciences

9h-index1.6kcitations59works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(21), Lung Cancer Treatments and Mutations(17), Cancer Treatment and Pharmacology(15), Gastric Cancer Management and Outcomes(11), Glioma Diagnosis and Treatment(7)

Publications58 total

Current Landscape and Evolving Role of Targeted Agents in Urothelial Carcinoma
Cancers·2026Open Access
P18.15.B DRUG SENSITIVITY OF RECURRENT GBM PATIENT-DERIVED ORGANOIDS CORRELATES WITH PATIENTS’ RESPONSE TO SECOND LINE CHEMOTHERAPY
Neuro-Oncology·2024Open Access
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma
ESMO Open·2024· 15 citedOpen Access
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression
Translational Oncology·2024· 5 citedOpen Access
CTNI-39. REGOMA-OS: A LARGE ITALIAN MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY ANALYZING REGORAFENIB EFFICACY AND SAFETY IN RECURRENT GLIOBLASTOMA PATIENTS
Neuro-Oncology·2023Open Access
507MO REGOMA-OS: A large Italian multicenter, prospective, observational study analyzing regorafenib efficacy and safety in recurrent glioblastoma patients
Annals of Oncology·2023· 1 cited
P17.02.B CORRELATIONS BETWEEN CLINICAL BENEFIT TO SECOND LINE REGIMENS AND NADH-FLIM-BASED DRUG RESPONSE ASSESSMENT MODEL ON RECURRENT GBM PATIENT-DERIVED ORGANOIDS
Neuro-Oncology·2023· 1 citedOpen Access
P17.07.A REGORAFENIB IN RECURRENT GLIOBLASTOMA PATIENTS: AN ITALIAN OBSERVATIONAL, MULTICENTRIC AND PROSPECTIVE TRIAL (REGOMA-OSS)
Neuro-Oncology·2023Open Access
P19.03.B IMPLEMENTATION OF RESECT CATEGORIES FOR EXTENT OF RESECTION STRESS THE LONG-TERM CLINICAL BENEFIT OF SUPRAMAXIMAL CONTRAST ENHANCING RESECTION IN A RETROSPECTIVE COHORT OF NEWLY DIAGNOSED IDH WT GLIOBLASTOMA PATIENTS
Neuro-Oncology·2023Open Access
Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study
Clinical and Experimental Medicine·2023· 1 citedOpen Access
Oncogene-addicted non-small-cell lung cancer in women: a narrative review of the importance of gender-related differences in treatment outcome
Precision Cancer Medicine·2022· 4 citedOpen Access
La gestione del tumore al polmone non a piccole cellule (NSCLC) ALK positivo – l’esperienza dell’Azienda USL Toscana Nord-Ovest
Drugs in Context·2021Open Access
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes
Anti-Cancer Agents in Medicinal Chemistry·2021· 8 cited
Caution advised regarding lung recruitment before surfactant – Authors’ reply
The Lancet Respiratory Medicine·2021Open Access
Fronto-mesial-pericallosal gliofibroma
Journal of Neurosurgical Sciences·2020· 2 cited
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy
Cancer Chemotherapy and Pharmacology·2019· 7 cited
ASTRIS, a real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC): preliminary analysis of the Italian cohort
Annals of Oncology·2017Open Access
A retrospective analysis of patients (pts) with non-small-cell lung cancer (NSCLC) with uncommon or complex epidermal growth factor receptor (EGFR) mutations treated with tyrosine kinase inhibitors (EGFR-TKIs): clinical features and outcome
Annals of Oncology·2017
Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer
Dove Medical Press (Taylor and Francis Group)·2014Open Access
Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer
Lung Cancer Targets and Therapy·2014· 5 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Alfredo Falcone(29), Fotios Loupakis(20), Lisa Salvatore(17), Gianluca Masi(17), Enrico Vasile(15), Giacomo Giulio Baldi(13), Lorenzo Fornaro(13), Samanta Cupini(12), Chiara Cremolini(9), Daniele Santini(9), Annamaria Ruzzo(8), Giuseppe Tonini(7), Mauro Magnani(7), Giacomo Allegrini(7), Francesco Graziano(6), M. Andreuccetti(6), Carmelo Tibaldi(6), Eleonora Bona(6), Romano Danesi(6), Bruno Vincenzi(5)